Our multidisciplinary Hematologic Malignancy Program focuses on the care of patients with lymphoma, leukemia, myeloma, myelodysplasias, myeloproliferative disorders, aplasia, or other neoplastic diseases of the marrow or blood system. More »
Drs. Gockerman, Diehl, Moore, and Rizzieri were all named by the Consumer's Research Council of America in their 'Guide to America's Top Oncologists'!
Dr. Arati Rao Recieved a grant from the 'Adler Foundation' to investigate the biology of leukemia in the elderly.
With his award from the Doris Duke Foundation, Dr. Sandeep Dave continues his leadership in applying genomics investigations to better understand the biology of lymphomas and how we may better target cancer cells.
Dr. Daphne Friedman was awarded the 'Barton Haynes Award' to help further her research into the genetic determinants of chronic leukemias.
Dr. Mark Lanasa has been awarded an NIH grant to continue his investigations into B cell disorders and what makes them develop into cancer.
Save the Date! Duke Debates - Controversies in the Management of Patients with Hematologic Malignancies
6th annual event planning is underway! Orlando March 19-20th AND Asheville, April 24-25th
Ann Vannostrand:
“When I was told I had cancer and the medicine my doctor tried didn't work, I was offered some choices of where to be treated. I knew there was one place I wanted to go - Duke!.” More Patient Stories »
DUKE UNIVERSITY
SCHOOL OF MEDICINE
DUKEHEALTH.ORG 
DHTS STRATEGIC WEB SERVICES